Tony has over 39 years’ experience in the development of manufacturing process and production of investigational biotherapeutics, 29 of these years, have been predominantly spent in the field of gene therapy and has been in the development of manufacturing processes for 4 licensed products including...
Novel Biotechnology Inc., a biotech company developing new solutions for plasmid DNA manufacturing – a critical starting material for gene therapy, cell engineering, mRNA therapy and vaccine applications – is pleased to welcome John Scott as VP, Business Development. John is an accomplished leader with 28...
Novel Biotechnology Inc., a biotech company developing new solutions for plasmid DNA manufacturing - a critical starting material for gene therapy, cell engineering, mRNA therapy and vaccine applications - is pleased to welcome Matthew Weinstock, PhD as Chief Technology Officer. Dr. Weinstock is an accomplished biotech...